Electroacupuncture preconditioning reduces cerebral ischemic injury via BDNF and SDF-1α in mice.

This study was designed to determine if electroacupuncture (EA) preconditioning improves tissue outcome and functional outcome following experimentally induced cerebral ischemia in mice. In addition, we investigated whether the expression of brain-derived neurotrophic factor (BDNF) and stromal cell derived factor-1α (SDF-1α) and infarct volume were related with improvement in neurological and motor function by interventions in this study.
After treatment with EA at the acupoints 'Baihui (GV20)' and 'Dazhui (GV14)' for 20 min, BDNF was assessed in the cortical tissues based on Western blot and the SDF-1α and vascular endothelial growth factor (VEGF) levels in the plasma determined by ELISA. To assess the protective effects of EA against ischemic injury, the mice received once a day 20 min EA preconditioning for three days prior to the ischemic event. Focal cerebral ischemia was then induced by photothrombotic cortical ischemia. Infarct volumes, neurobehavioral deficit and motor deficit were evaluated 24 h after focal cerebral ischemia.
The expression of BDNF protein increased significantly from 6 h, reaching a plateau at 12 h after the end of EA treatment in the cerebral cortex. Furthermore, SDF-1α, not VEGF, increased singnificantly from 12 h to 48 h after EA stimulation in the plasma. Moreover, EA preconditioning reduced the infarct volume by 43.5% when compared to control mice at 24 h after photothrombotic cortical ischemia. Consistent with a smaller infarct size, EA preconditioning showed prominent improvement of neurological function and motor function such as vestibule-motor function, sensori-motor function and asymmetric forelimb use. The expression of BDNF colocalized within neurons and SDF-1α colocalized within the cerebral vascular endothelium was observed throughout the ischemic cortex by EA.
Pretreatment with EA increased the production of BDNF and SDF-1α, which elicited protective effects against focal cerebral ischemia. These results suggest a novel mechanism of EA pretreatment-induced tolerance against cerebral ischemic injury.
AuthorsJi Hyun Kim, Kyung Ha Choi, Young Jung Jang, Ha Neui Kim, Sun Sik Bae, Byung Tae Choi, Hwa Kyoung Shin
JournalBMC complementary and alternative medicine (BMC Complement Altern Med) Vol. 13 Pg. 22 ( 2013) ISSN: 1472-6882 [Electronic] England
PMID23356671 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Brain-Derived Neurotrophic Factor
  • Chemokine CXCL12
  • Vascular Endothelial Growth Factor A
  • Acupuncture Points
  • Animals
  • Brain (drug effects, metabolism, physiology)
  • Brain Injuries (metabolism, physiopathology, prevention & control)
  • Brain Ischemia (metabolism, physiopathology, therapy)
  • Brain-Derived Neurotrophic Factor (metabolism)
  • Cerebral Infarction (metabolism, physiopathology, prevention & control)
  • Chemokine CXCL12 (metabolism)
  • Electroacupuncture
  • Endothelium, Vascular (metabolism)
  • Forelimb
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: